Home » Press Release » 2013 » November 12, 2013

November 12, 2013

Alethia Biotherapeutics announces the issuance of U.S. Patent No. 8,580,257  entitled “Antibodies that specifically block the biological activity of kidney associated antigen 1 (KAAG1)” by the United States Patent and Trademark Office (“USPTO”)